Products and services
  • Mass Production and CDMO
Mass Production and CDMO

The mass production process of stem cells developed by UnicoCell can increase the yield of a single batch compared to the traditional culture method. By increasing the yield, the production cost is significantly reduced with the price of cellular products more affordable for the regenerative medical needs and disease treatment.

Product Description

Mass Production Techology

UnicoCell has made an important breakthrough in the development of automated mass production technology for cell therapy product.
With scalable mass production bioreactor and downstream automated cell concentration and purification dispensing equipment, our mass production technology builds an important foundation for Phase III (Pivotal study) and future commercial production or CDMO. For information on mass production technology and CDMO services, please contact